Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Bruijnen, Stefan T G ^a   van der Weijden, Mignon A C ^a,b   Klein, Joannes P ^a   Hoekstra, Otto S ^a   Boellaard, Ronald ^a   van Denderen, J Christiaan ^b   Dijkmans, Ben A C ^a,b   Voskuyl, Alexandre E ^a   van der Horst Bruinsma, Irene E ^a   van der Laken, Conny J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Jan Van Breemen Research Institute   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; CARBON; DIAGNOSTIC AGENT;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFLAMMATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PILOT STUDY; SPINE RADIOGRAPHY; BONE DEVELOPMENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

ADULT; CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OSTEOGENESIS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; SPONDYLITIS, ANKYLOSING; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84859134386     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3792     Document Type: Article

References (48)

1. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002, 61(Suppl 3):iii8-18. 1766729, 12381506.
2. Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005, 52:1756-1765. 10.1002/art.21054, 15934081.
3. Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004, 63:665-670. 10.1136/ard.2003.016386, 1755042, 15037444.
4. Haibel H, Sieper J. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?. Curr Opin Rheumatol 2010, 22:388-392. 10.1097/BOR.0b013e32833aaf93, 20473176.
5. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368. 10.1002/art.1780270401, 6231933.
6. Rostom S, Dougados M, Gossec L. New tools for diagnosing spondyloarthropathy. Joint Bone Spine 2010, 77:108-114. 10.1016/j.jbspin.2009.12.005, 20153677.
7. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004, 63:535-543. 10.1136/ard.2003.011247, 1754994, 15082484.
8. Maksymowych WP, Lambert RG. Magnetic resonance imaging for spondyloarthritis--avoiding the minefield. J Rheumatol 2007, 34:259-265.
9. Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, Marzo-Ortega H, Ostergaard M, Braun J, Sieper J. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009, 68:1520-1527. 10.1136/ard.2009.110767, 19454404.
10. Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, Rudwaleit M, Zuehlsdorf S, Bollow M, Sieper J, van der Heijde D. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional × rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 2004, 63:1046-1055. 10.1136/ard.2003.019968, 1755114, 15066862.
11. Weber U, Hodler J, Kubik RA, Rufibach K, Lambert RG, Kissling RO, Pfirrmann CW, Maksymowych WP. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis Rheum 2009, 61:900-908. 10.1002/art.24507, 19565558.
12. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans B, Dougados M, Emery P, van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlam K, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009, 68:770-776. 10.1136/ard.2009.108217, 19297345.
13. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777-783. 10.1136/ard.2009.108233, 19297344.
14. Maksymowych WP. MRI in ankylosing spondylitis. Curr Opin Rheumatol 2009, 21:313-317. 10.1097/BOR.0b013e32832af481, 19496307.
15. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996, 23:207-211. 10.1007/BF01731847, 8925858.
16. Elzinga EH, van der Laken CJ, Comans EF, Boellaard R, Hoekstra OS, Dijkmans BA, Lammertsma AA, Voskuyl AE. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med 2011, 52:77-80. 10.2967/jnumed.110.076711, 21149486.
17. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006, 238:405-422. 10.1148/radiol.2382041977, 16436809.
18. Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol 2010, 6:75-81. 10.1038/nrrheum.2009.258, 20125174.
19. Frost ML, Cook GJ, Blake GM, Marsden PK, Benatar NA, Fogelman I. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. J Bone Miner Res 2003, 18:2215-2222. 10.1359/jbmr.2003.18.12.2215, 14672357.
20. Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 2010, 6:399-405. 10.1038/nrrheum.2010.79, 20517295.
21. Muche B, Bollow M, Francois RJ, Sieper J, Hamm B, Braun J. Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 2003, 48:1374-1384. 10.1002/art.10934, 12746910.
22. Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Kaiser MJ, Hustinx R, Foidart J, Malaise MG. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004, 45:956-964.
23. Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 2007, 9:357-360. 10.1007/s11307-007-0113-4, 2040173, 17902022.
24. van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, Boellaard R, Dijkmans BA, Lammertsma AA, Voskuyl AE. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis Rheum 2008, 58:3350-3355. 10.1002/art.23955, 18975347.
25. Canat X, Guillaumont A, Bouaboula M, Poinot-Chazel C, Derocq JM, Carayon P, LeFur G, Casellas P. Peripheral benzodiazepine receptor modulation with phagocyte differentiation. Biochem Pharmacol 1993, 46:551-554. 10.1016/0006-2952(93)90535-5, 8394087.
26. Baeten D, Kruithof E, De Rycke L, Boots AM, Mielants H, Veys EM, De Keyser F. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther 2005, 7:R359-R369. 10.1186/ar1501, 1065336, 15743484.
27. Fischer DR, Maquieira GJ, Espinosa N, Zanetti M, Hesselmann R, Johayem A, Hany TF, von Schulthess GK, Strobel K. Therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain. Skeletal Radiol 2010, 39:987-997. 10.1007/s00256-010-0875-7, 20174985.
28. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000, 88:2927-2933. 10.1002/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V, 10898336.
29. Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, Johayem A, von Schulthess GK, Michel BA, Ciurea A. 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging 2010, 37:1760-1765. 10.1007/s00259-010-1464-7, 20505935.
30. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003, 2:131-137. 10.1162/153535003322556877, 14649056.
31. Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O, Lenza A, Cavallini M, Scopinaro F, Signore A. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?. J Nucl Med 2011, 52:1012-1019. 10.2967/jnumed.110.082222, 21680679.
32. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, Reske SN. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998, 206:749-754.
33. Bhargava P, Naydich M, Ghesani M. Normal F-18 FDG vertebral uptake in Paget's disease on PET scanning. Clin Nucl Med 2005, 30:191-192. 10.1097/00003072-200503000-00012, 15722827.
34. Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, . ASAS Working Group First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006, 65:316-320. 10.1136/ard.2005.040758, 1798064, 16096329, ASAS Working Group.
35. Cook GJ, Maisey MN, Fogelman I. Fluorine-18-FDG PET in Paget's disease of bone. J Nucl Med 1997, 38:1495-1497.
36. Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005, 64:127-129. 10.1136/ard.2004.020503, 1755183, 15051621.
37. Woo JH, Kim S, Choi SJ, Lee YH, Ji JD, Song GG. Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT. Int J Rheum Dis 2010, 13:e51-e54. 10.1111/j.1756-185X.2010.01538.x, 21199453.
38. Huyge V, Garcia C, Vanderstappen A, Alexiou J, Gil T, Flamen P. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Clin Nucl Med 2009, 34:417-420. 10.1097/RLU.0b013e3181a7d03c, 19542943.
39. Piert M, Zittel TT, Becker GA, Jahn M, Stahlschmidt A, Maier G, Machulla HJ, Bares R. Assessment of porcine bone metabolism by dynamic. J Nucl Med 2001, 42:1091-1100.
40. Ben Ali K, Poisson T, Compaore C, Lebtahi R, Sarda-Mantel L, Burg S, Wattiaux MJ, Meyer O, Hayem G, Le Guludec D. Interest of NaF-PET/CT in SAPHO syndrome. J Nucl Med Meeting Abstracts 2010, 51:1641.
41. Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol 2006, 187:1420-1426. 10.2214/AJR.05.1423, 17114530.
42. Goh L, Suresh P, Gafoor A, Hughes P, Hickling P. Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings. Clin Rheumatol 2008, 27:449-455. 10.1007/s10067-007-0726-7, 17912578.
43. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D, . Assessment of SpondyloArthritis international Society Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68:18-24. Assessment of SpondyloArthritis international Society.
44. Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D, . Assessment of SpondyloArthritis international Society Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011, 70:47-53. 10.1136/ard.2010.138594, 21068095, Assessment of SpondyloArthritis international Society.
45. Machado P, van der Heijde D. How to measure disease activity in axial spondyloarthritis?. Curr Opin Rheumatol 2011, 23:339-345. 10.1097/BOR.0b013e3283470f23, 21519269.
46. Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S. Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. Skeletal Radiol 2008, 37:123-131. 10.1007/s00256-007-0407-2, 18034343.
47. Madsen KB, Jurik AG. Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint. Arthritis Care Res (Hoboken) 2010, 62:11-18.
48. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009, 60:93-102. 10.1002/art.24132, 19116919.